Alitretinoin topical Pregnancy and Breastfeeding Warnings
Alitretinoin topical is also known as: Panretin
Alitretinoin topical Pregnancy Warnings
Alitretinoin topical has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of fetotoxicity and teratogenicity with oral doses of alitretinoin above the recommended human dose (adjusted for body surface area). Topical alitretinoin has not been studied in animal models. There are no controlled data in human pregnancy. Patients should be advised of the potential harm to the fetus if alitretinoin topical is used during pregnancy or if they become pregnant while using it. Women of childbearing potential should be advised to avoid becoming pregnant. Alitretinoin topical is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.
Alitretinoin topical Breastfeeding Warnings
There are no data on the excretion of alitretinoin topical into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, mothers should discontinue nursing prior to using the drug.
- alitretinoin Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.